Cas:69288-33-1 2,4-Henicosadiynoic acid manufacturer & supplier

Chemical Name:2,4-Henicosadiynoic acid

CAS.NO:69288-33-1

Synonyms:2,4-Heneicosadiynoic acid;Henicosa-2,4-diynoic acid;2,4-Henicosadiynoic acid

Molecular Formula:C₂₁H₃₄O₂

Molecular Weight:318.493

HS Code:2916190090

Physical and Chemical Properties:

Melting point:75ºC

Boiling point:444.8±28.0 °C at 760 mmHg

Density:0.9±0.1 g/cm3

Index of Refraction:1.488

PSA:37.30000

Exact Mass:318.255890

LogP:10.36

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2,4-Heneicosadiynoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,4-Henicosadiynoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,4-Heneicosadiynoic acid Use and application,2,4-Heneicosadiynoic acid technical grade,usp/ep/jp grade.

Related News: The survival benefit is “unprecedented” for an aging myeloma population, almost all of whom were 65 years of age or older, said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. 2,4-Henicosadiynoic acid manufacturer Right now, midstage data for Roche-AC Immune’s anti-tau antibody semorinemab in moderate Alzheimer’s are expected later this year, but it has already failed a phase 2 study in mild disease. 2,4-Henicosadiynoic acid supplier In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase. 2,4-Henicosadiynoic acid vendor In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase. 2,4-Henicosadiynoic acid factory he agency said the drugmaker and Emergent must agree that the FDA can share relevant information about the manufacturing of the doses with regulators where the vaccine is shipped.